Experimental design of the study. Seventy C57BL/6J mice were randomly divided into
two treatment groups (n=35 for each group). (A) Group I: mice were instilled
intratracheally with B(a)p (1 mg/mouse) and lipopolysaccharide (LPS) (5
µg/mouse), once a week for 4 times, on Tuesday and Friday,
respectively. At Week 4, mice continued to be treated with LPS, once every four
weeks for 5 times. (B) Group II: mice were exposed to B(a)p (1 mg/mouse, once a week
for 4 times) and 3 weeks later instilled intratracheally with LPS (2.5
µg/mouse) once every three weeks for 5 times. Thirty weeks after
the week of the last dose of B(a)p, mice were anaesthesia by pentobarbital
sodium.